[What is achieved by the therapy with oral antidiabetics?].
D000284:Administration, Oral; D000328:Adult; D001645:Biguanides / Q000008:administration & dosage / Q000009:adverse effects; D002747:Chlorpropamide / Q000008:administration & dosage / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000178:diet therapy / Q000628:therapy; D003925:Diabetic Angiopathies / Q000517:prevention & control; D004347:Drug Interactions; D005905:Glyburide / Q000008:administration & dosage / Q000494:pharmacology; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009765:Obesity; D010629:Phenformin / Q000009:adverse effects / Q000627:therapeutic use; D011446:Prospective Studies; D012189:Retrospective Studies
D001645:Biguanides; D007004:Hypoglycemic Agents; D010629:Phenformin; D005905:Glyburide; D002747:Chlorpropamide
Was ist gesichert in der Therapie mit oralen Antidiabetika